JPRN-jRCTs052210098已完成未知
Safety and efficacy of the stabilizer device using in endovascular therapy for cerebral aneurysm
sakai nobuyuki0 个研究点目标入组 5 人开始时间: 2021年10月4日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 5
研究概览
简要总结
Primary endpoint, defined hemorrhagic complication, did not occur because the trial device was stable without unexpected movements. Secondary endpoint for safety, defined 1; ischemic stroke, 2; arterial dissection, 3; vasospasm, did not occur. 4; other adverse event, transient finger fine movement disturbance occurred just after treatment in 1 case, but disappeared spontaneously and no ischemic change on MRI at next day of treatment. This even is not related to device and treatment.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 80age old(—)
- 性别
- All
入选标准
- •1)Patients who are scheduled to have a flow divertor or coil-assisted stent for cerebral aneurysm
- •2) Patients who are expected to have difficulty delivering the catheter to the treatment site.
- •3)Patients aged between 20years and 80years old at the time of concent acquisition
- •4)Patients who consented to the study in writing
排除标准
- •1)A history of hypersensitivity to nickel or titanium
- •2)A patient who is judged by the principal investigator to be inappropriate in this study
研究者
相似试验
已完成
1 期
Safety and effecacy of the Anchor Wirecerebrovascular diseaseJPRN-jRCTs052200012Sakai Nobuyuki10
进行中(未招募)
不适用
Safety and efficacy of the stabilizer device using in endovascular therapyJPRN-jRCT2052220056Sakai Nobuyuki30
尚未招募
不适用
Immediate effects of different Physical Therapy Techniques in the Balance of non-exercising elderly womeSedentary LifestyleAgedM01.060.116.100F01.145.749RBR-263wr8IVERSIDADE FEDERAL DO RIO GRANDE DO SUL - ESCOLA DE EDUCAÇÃO FÍSICA FISIOTERAPIA E DANÇA
已完成
不适用
Stabilization Splint Treatment of TMDFacial PainTemporomandibular DisorderNCT05240703University of Oulu80
Unknown
不适用
Safety and Efficacy of a Device for the Relief of Pain Due to Carpal Tunnel SyndromeCarpal Tunnel SyndromeNCT03810326Yuinvent Innovations Ltd.40
